FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/7/2026
Cowen analyst Joshua Jennings reiterated an Outperform rating and $33.00 price target on Outset Medical Inc. (NASDAQ: OM).
The analyst comments "OM Has Received a New 510(k) Clearance for the Tablo Hemodialysis System. In a decision dated July 29, 2022, the FDA cleared a new 510(k)... More
Stifel analyst Rick Wise reiterated a Buy rating and $24.00 price target on Outset Medical Inc. (NASDAQ: OM).
The analyst comments "Last Friday, Outset received a positive FDA update on its Tablo catch-up 510K filing, with the agency providing a substantially-equivalent decision on the filing.... More

